12/4
04:05 pm
imnm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/1
08:45 am
imnm
Immunome (NASDAQ:IMNM) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $36.00 price target on the stock.
Low
Report
Immunome (NASDAQ:IMNM) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $36.00 price target on the stock.
11/25
08:45 am
imnm
Immunome to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Immunome to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/25
08:00 am
imnm
Immunome to Present at Upcoming Investor Conferences
Low
Report
Immunome to Present at Upcoming Investor Conferences
11/22
02:11 am
imnm
Low
Report
11/17
08:06 am
imnm
Immunome (NASDAQ:IMNM) had its price target raised by analysts at Stephens from $25.00 to $33.00. They now have an "overweight" rating on the stock.
Low
Report
Immunome (NASDAQ:IMNM) had its price target raised by analysts at Stephens from $25.00 to $33.00. They now have an "overweight" rating on the stock.
11/8
01:18 pm
imnm
Medium
Report
11/7
11:30 pm
imnm
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
Medium
Report
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
11/6
11:31 pm
imnm
Immunome GAAP EPS of -$0.65 [Seeking Alpha]
Low
Report
Immunome GAAP EPS of -$0.65 [Seeking Alpha]
11/6
04:05 pm
imnm
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
11/4
04:05 pm
imnm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/31
11:51 am
imnm
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
Low
Report
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
10/23
12:00 pm
imnm
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
Low
Report
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
10/8
12:25 pm
imnm
Immunome (NASDAQ:IMNM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Immunome (NASDAQ:IMNM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/2
05:05 pm
imnm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/27
10:48 am
imnm
Will Immunome's (IMNM) Antibody Collaboration Refocus Its Pipeline Expansion Strategy? [Yahoo! Finance]
Medium
Report
Will Immunome's (IMNM) Antibody Collaboration Refocus Its Pipeline Expansion Strategy? [Yahoo! Finance]
9/23
06:11 am
imnm
Immunome (NASDAQ:IMNM) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Medium
Report
Immunome (NASDAQ:IMNM) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
9/22
08:05 am
imnm
Immunome (NASDAQ:IMNM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Low
Report
Immunome (NASDAQ:IMNM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $26.00 price target on the stock.
9/18
11:23 am
imnm
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
Medium
Report
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
9/18
08:00 am
imnm
Infinimmune Announces Research Collaboration with Immunome
Medium
Report
Infinimmune Announces Research Collaboration with Immunome